Source:http://linkedlifedata.com/resource/pubmed/id/19461506
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2009-7-27
|
pubmed:abstractText |
High-grade transformation of acinic cell carcinoma (AciCC) (previously referred to as dedifferentiation) is a rare phenomenon characterized by histologic progression of low-grade AciCC to high-grade adenocarcinoma or undifferentiated carcinoma. We report 9 new cases with immunohistochemical analysis and examination of HER-2/neu and p53 genes to further define the profile of this tumor. Histologically, the high-grade component was composed of polymorphic cells with a high mitotic rate arranged in glandular and solid growth patterns with comedonecrosis. The MIB-1 labeling indices were elevated in the high-grade component, as compared with the low grade conventional AciCC. The high-grade component of AciCC was characterized by strong membrane staining for CK18 and beta-catenin, and nuclear staining for cyclin-D1. HER-2/neu, androgen receptor, C-kit, and epidermal growth factor receptor were absent from both low-grade and high-grade components. In contrast, S-100 protein, alpha-1-antitrypsin, and lysozyme were lost only in high-grade foci of transformed AciCC. The median age was 61 years (with range from 43 to 76 y). Lymph node (LN) metastases were found in 5 of 9 cases (56%). Distant metastases to the lungs (n=4), pleura (n=2), brain (n=3), and peritoneum (n=1), and paraaortic, paratracheal, and mediastinal LNs (n=2) were observed. Six of 9 patients (66%) died from tumor dissemination, all with a median overall survival of 4.3 years (range: 1 to 9 y). The high propensity for LN metastases indicates the need for neck dissection at the time of diagnosis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1532-0979
|
pubmed:author |
pubmed-author:CurikRomualdR,
pubmed-author:ElmbergerGoranG,
pubmed-author:JedlickovaKristinaK,
pubmed-author:KorabecnaMarieM,
pubmed-author:LeivoIlmoI,
pubmed-author:MarieGeierovaG,
pubmed-author:MullerSusanS,
pubmed-author:NemcovaJanaJ,
pubmed-author:Passador-SantosFabricioF,
pubmed-author:RousarovaMilenaM,
pubmed-author:SimaRadekR,
pubmed-author:SkálováAlenaA,
pubmed-author:VanecekTomasT,
pubmed-author:WalterJiriJ,
pubmed-author:XXX
|
pubmed:issnType |
Electronic
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1137-45
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:19461506-Adult,
pubmed-meshheading:19461506-Aged,
pubmed-meshheading:19461506-Carcinoma, Acinar Cell,
pubmed-meshheading:19461506-Cell Transformation, Neoplastic,
pubmed-meshheading:19461506-DNA Mutational Analysis,
pubmed-meshheading:19461506-Female,
pubmed-meshheading:19461506-Genes, erbB-2,
pubmed-meshheading:19461506-Genes, p53,
pubmed-meshheading:19461506-Humans,
pubmed-meshheading:19461506-Immunohistochemistry,
pubmed-meshheading:19461506-In Situ Hybridization, Fluorescence,
pubmed-meshheading:19461506-Male,
pubmed-meshheading:19461506-Middle Aged,
pubmed-meshheading:19461506-Parotid Neoplasms,
pubmed-meshheading:19461506-Receptor, erbB-2,
pubmed-meshheading:19461506-Tumor Markers, Biological,
pubmed-meshheading:19461506-Tumor Suppressor Protein p53
|
pubmed:year |
2009
|
pubmed:articleTitle |
Acinic cell carcinoma with high-grade transformation: a report of 9 cases with immunohistochemical study and analysis of TP53 and HER-2/neu genes.
|
pubmed:affiliation |
Department of Pathology, Charles University in Prague, Faculty of Medicine, 305 99 Pilsen, Czech Republic. skalova@fnplzen.cz
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|